Gastrointestinal Pharmacology III Flashcards
What strategies are utilized by antidiarrheals?
- thicken stool and reduce intestinal smooth muscle contraction
- treat symptoms
- should be avoided in infection-caused acute diarrhea
- can mask symptoms and delay the treatment of infection
What opioids are used as antidiarrheals?
mechanism of action?
clinical uses?
Adverse effects?
drug-drug interactions?
- drugs
- Loperamide (diamode)
- diphenoxylate
- mechanism of action
- stimulate opiate receptors (micro and delta) on enteric neurons and inhibiting presynaptic cholinergic action
- suppress smooth muscle contraction
- enhance mucosal absorption
- decrease gastrocolic reflex
- stimulate opiate receptors (micro and delta) on enteric neurons and inhibiting presynaptic cholinergic action
- metabolism
- substrate of CYP2C8, CYP3A4, and pg-protein
- Clinical uses
- treate travelers diarrhea and chronic diarrhea
- Loperamide: nonprescription drug
- High dose: arrhythmia
- Diphenoxylate: prescription drug
- higher dose: central nervous effects
- long-term use: dependence
- commercial preparations: combined with atropine (lomotil) to prevent overdose
- Loperamide: nonprescription drug
- treate travelers diarrhea and chronic diarrhea
- Adverse effects
- constipation and dry mouth (b/c decrease effects ACh)
- Drug-drug interactions
- loperamide with inhibitors of CYP3A4, 2C8, and pg-protein
- some patients will take high dose of loperamide to achieve euphoria & take inhibitors of CYP3A4, 2C8, and pg-protein, purposefully reducing the metabolism & achieve euphoric effects
- will results in arrhythmia
- some patients will take high dose of loperamide to achieve euphoria & take inhibitors of CYP3A4, 2C8, and pg-protein, purposefully reducing the metabolism & achieve euphoric effects
- loperamide with inhibitors of CYP3A4, 2C8, and pg-protein
What type of drugs are Kaolin & Pectin?
Mechanism of Action?
Clinical use?
additional considerations?
- Adsorbents
- Kaolin: hydrated magnesium aluminum silicate
- Pectin: indigestible carbohydrates
- Mechanism of Action
- adsorbents of bacteria, toxin, and fluid
- Clinical use
- often administered to kids to treat acute diarrhea
- Additional considerations
- should be taken within 2 hours of other drugs
What type of drug is bismuth subsalicylate?
Mechanism of Action?
Use?
- Adsorbents
- mechanism of action: not clear
- salicylate: reduce chloride secretion
- bismuth: binds to bacteria and enterotoxin
- clinical use
- prevent and treat traveler’s diarrhea
- short term
What type of drug is bile salt-binding resins
Mechanism of Action?
Use?
- Adsorbent
- colestipol: colestid
- cholestyramine: loCHOLEST
- Mechanism of Action
- bind to bile
- Clinical use
- reat bile malabsorption-caused diarrhea
What is the synthetic somatostatin drug?
Mechanism of Action?
Adminstration?
- Octreotide (sandostatin)
- Mechanism of Action
- Inhibit secretion of 5-HT, gastrin, glucagon, growth hormone, insulin, secretin, pancreatic polypeptide, VIP, cholecytokinin, adn pituitary hormones
- reduce fluid secretion
- slow GI motility and inhibits gallbladder contraction
- Route: IV, subQ, or IM
Clinical uses of octreotide?
- Synthetic somatostatin
- Clinical uses
- treat secretory diarrhea caused by endocrine tumor (carcinoid, VIPoma)
- high dose (100-250 micrograms): treat diarrhea caused by vagotomy or dumping dyndrome, short bowel syndrom or AIDS
- treat pancretic fistula
- treat pituitary tumors
- Adverse effects
- lipid-soluble vitamin deficiency
- gallstones
- nausea, abdominal pain, flatulence, and diarrhea
- hyper- and hypo-glycemia
- hypothyroidism, bradycardia
What is the Tryptophan hydroxylase inhibitor drug?
Mechanism of Action
Clinical use?
Adverse effects?
- Drug: telotristat ethyl (Xermelo)
- Mechanism of Action
- Inhibit the enzyme that converts L-tryptophan to 5-hydroxy-tryptophan (tryptophan hydroxylase)
- leads to a subsequent decrease in seratonin
- Inhibit the enzyme that converts L-tryptophan to 5-hydroxy-tryptophan (tryptophan hydroxylase)
- Clinical use
- combined witha somatostatin analogue
- carcinoid syndrome diarrhea that is not adequately controlled by a somatostatin analogue alone
- combined witha somatostatin analogue
- Adverse effects
- most common
- nausea, headache, depression, flatulence, decreased appetite, peripheral edema, fever, adn liver enzyme elvations
- large dose: constipation
- most common
What is the name of the chloride channel inhibitor?
Mechanism of action?
clinical uses?
Adverse effects?
- crofelemer
- Mechanism of Action
- inhibit the secretion of chloride ions into the intestine
- Clinical uses
- antiretroviral-induced diarrhea
- provide symptom relief
- Adverse effects
- upper respiratory infection
- flatulence
- and increased bilirubin
Identify the location of receptors for antemetic drugs
- Chemoreceptor trigger zone
- CNS
- Vestibular system
- Pharynx
- Vagal adn spinal afferent nerves in GI
- Chemoreceptor trigger zone
- D2
- NK1
- 5-HT3
- CNS
- H1
- M1
- NK1
- 5-HT3
- Vestibular system
- M1
- H1
- Pharynx
- M1
- Vagal and spinal afferent nerves in GI
- 5-HT3
What drug classes are used to prevent and treat nausea and vomiting?
- antagonists for
- NK1
- 5-HT3
- D2
- M1
- H1
- others
- benzodiazepines
- CB1 agonists
What are the causes of emesis?
- Chemotherapy
- Acute (24 hrs, 5-HT3)
- delayed (48 hrs to several days, neurokinin)
- anticipatory
- motion sickness
- others
- non-chemotherapy drug-induced emesis
- infections
- PONV (postoperative nausea and vomiting)
- Radiation
- Pregnancy
- Disease
What are the 5-HT3 antagonists?
mechanism of action?
clinical uses?
Adverse effects?
- Drugs (-setrond)
- ondabsetron
- dolasetron
- grabisetron
- palonosetron
- Mechanism of action
- blocking both central and perioheral 5-HT3 receptors
- Clinical uses
- 5-HT3 antagonist + dexamethasone (corticosteroid)
- the most effective therapy for prevention of chemotherapy-induced acute severe vomiting
- prevent and treat acute emesis caused by radiation and postoperation
- 5-HT3 antagonist + dexamethasone (corticosteroid)
- Adverse effects
- headache
- constipation
- dizziness
- prolonged QT intercal (antibiotics?)
What are the NK1-antagonists?
mechanism of action?
clinical uses?
Adverse effects?
- drugs (-pitants)
- Aprepitant (Emend)
- fosaprepitant
- rolapitant (Varubi)
- MOA
- blocking central NK1 receptors
- Clinical uses
- NK1 antagonists + dexamethasome
- prevent delayed emesis caused by chemotherapy
- NK1 antagonists + 5-HT3 antagonists + dexamethasone
- prevent acute adn delayed emesis caused by chemotherapy
- NK1 antagonists + dexamethasome
- Adverse Effects
- all drugs are the substrates of CYP3A4, interact wth CYP3A4 inducers and inhibitors
- Rolapitant: also a substrate of p-gp, interacts with p-gp inhibitors adn inducers
- Cmmon adverse effects: hiccups, decreased appetite, and dizziness
- Rolapitant also causes neutropenia and allergic reactions
What are the benzodiazepines?
Mechanisms of Action?
Clinical use?
- Drugs
- Lorazepam (Ativan)
- diazepam
- Mechanisms of Action
- enhance GABA’s effect on chloride ion conductance leading to sedation, hypnosis, anesthesia, etc.
- Clnical uses
- prevent anticipatory nausea and vomiting prior to the initiation of chemotherapy